money.rediff.com

Maruti Suzuki Forecasts Continued Growth in India’s Premium Hatchback Segment

Maruti Suzuki India logoMaruti Suzuki India
Sig1.53Sen+2.95Env0.00Soc0.00Gov0.00

Maruti Suzuki predicts strong growth for India’s premium hatchback segment. Other market updates include Fosun Pharma selling a 4.5% stake in Gland Pharma for ₹2,121 crore, Jio expanding globally after a decade in India, and NCLT ordering a status quo on the sale of Byju’s K3 Education assets. Piyush Goyal inaugurates a skill centre in North Mumbai, Cyrix Healthcare buys Blue Star E&E medtech, and Bengaluru bullion rates track gold and silver.

Coverage (2)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro